Use of synergistic bacteriophage lytic enzymes for prevention and treatment of bacterial infections
Details for Australian Patent Application No. 2003303338 (hide)
International Classifications
Event Publications
19 August 2004 Complete Application Filed
Priority application(s): 60/436,077 23.12.02 US
26 August 2004 Application Open to Public Inspection
Published as AU-B-2003303338
9 April 2009 Application Accepted
Published as AU-B-2003303338
30 July 2009 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 06 Jul 2009. Address for service in Australia - Madderns Level 1 64 Hindmarsh Sq Adelaide SA 5000 2004
26 November 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 06 Jul 2009 2004
26 November 2009 Standard Patent Sealed
21 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003303339-Lymphotoxin beta receptor agents in combination with chemotherapeutic agents
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser